based Sami Labs limited, a Rs 250 crore healthscience organisation,
has announced its plans to expand its presence in the global
market through a renewed focus on discovery and intellectual
Property. The company’s 3 new active ingredients-
Tetrahydrocurcuminoids (THC), Coleus oil and ZeaLutien have
been approved and are set to revolutionise the dermatology,
infective and geriatric ophthalomology markets.